IDEAL DOSE OF ACETYLSALICYLIC ACID FOR CARDIAC PATIENTS: THE SEARCH IS OVER?
.
Main Author: | O. V. Averkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2011-08-01
|
Series: | Российский кардиологический журнал |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1134 |
Similar Items
-
ACETYLSALICYLIC ACID AND PREVENTION OF FATAL OUTCOMES IN CARDIOVASCULAR DISEASE: SELECTING MEDICATION FORM AND DOSE
by: O. V. Averkov
Published: (2012-08-01) -
Acetylsalicylic acid as an anti-platelet agent: what forms should be used, according to evidence-based medicine?
by: O. V. Averkov
Published: (2010-04-01) -
Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk
by: O. V. Averkov
Published: (2021-02-01) -
Cost-minimization analysis of application acetylsalicylic acid in cardiac elderly patients
by: D. Yu. Belousov, et al.
Published: (2018-05-01) -
Assessment of efficacy of single dose acetylsalicylic acid over a 24-hour period
by: Reşat Mehmet Baha, et al.
Published: (2015-07-01)